ZA9110145B - 14beta-h-,14-and 15-en-11beta-aryl-4-oestrenes - Google Patents

14beta-h-,14-and 15-en-11beta-aryl-4-oestrenes

Info

Publication number
ZA9110145B
ZA9110145B ZA9110145A ZA9110145A ZA9110145B ZA 9110145 B ZA9110145 B ZA 9110145B ZA 9110145 A ZA9110145 A ZA 9110145A ZA 9110145 A ZA9110145 A ZA 9110145A ZA 9110145 B ZA9110145 B ZA 9110145B
Authority
ZA
South Africa
Prior art keywords
hydrogen atom
pct
bond
configuration
together represent
Prior art date
Application number
ZA9110145A
Other languages
English (en)
Inventor
Wolfgang Schwede
Schwede Wolfgang
Guenter Neef
Neef Guenter
Krzysztof Chwalisz
Chwalisz Krzysztof
Ulrike Fuhrmann
Fuhrmann Ulrike
Eckhard Ottow
Ottow Eckhard
Arwed Cleve
Cleve Arwed
Horst Michna
Michna Horst
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA9110145B publication Critical patent/ZA9110145B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0092—Alkenyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Internal Circuitry In Semiconductor Integrated Circuit Devices (AREA)
  • Luminescent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Electron Beam Exposure (AREA)
  • Amplifiers (AREA)
ZA9110145A 1990-12-22 1991-12-23 14beta-h-,14-and 15-en-11beta-aryl-4-oestrenes ZA9110145B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4042004A DE4042004A1 (de) 1990-12-22 1990-12-22 14(beta)-h-, 14- u. 15-en-11(beta)-aryl-4-estrene

Publications (1)

Publication Number Publication Date
ZA9110145B true ZA9110145B (en) 1992-11-25

Family

ID=6421576

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9110145A ZA9110145B (en) 1990-12-22 1991-12-23 14beta-h-,14-and 15-en-11beta-aryl-4-oestrenes

Country Status (14)

Country Link
US (1) US5426102A (xx)
EP (1) EP0567469B1 (xx)
JP (1) JP3048636B2 (xx)
CN (1) CN1066271A (xx)
AT (1) ATE157372T1 (xx)
AU (1) AU659118B2 (xx)
CA (1) CA2099016A1 (xx)
DE (2) DE4042004A1 (xx)
FI (1) FI932872A (xx)
HU (1) HUT65320A (xx)
IE (1) IE914530A1 (xx)
PT (1) PT99910B (xx)
WO (1) WO1992011278A1 (xx)
ZA (1) ZA9110145B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6900193B1 (en) * 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
JP4260886B2 (ja) * 1996-05-01 2009-04-30 アメリカ合衆国 新規の抗プロゲステロンとしての２１―置換プロゲステロン誘導体
US6090798A (en) * 1997-12-19 2000-07-18 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with glucocorticoid antagonists
CA2516319C (en) * 2003-02-28 2012-09-18 The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services Method for preparing 17.alpha.-acetoxy-11.beta.-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates
DE102007011105A1 (de) * 2007-03-02 2008-09-04 Bayer Schering Pharma Aktiengesellschaft Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose
PL2576582T3 (pl) 2010-05-26 2020-06-29 Corcept Therapeutics, Inc. Leczenie dystrofii mięśniowej
AU2016226451B2 (en) 2015-03-02 2019-12-19 Corcept Therapeutics, Inc. Use of glucocorticoid receptor antagonist and somatostatin analogues to treat ACTH-secreting tumors
MX2017011885A (es) 2015-03-30 2018-02-19 Corcept Therapeutics Inc Uso de antagonistas de receptores de glucocorticoides en combinacion con glucocorticoides para tratar la insuficiencia adrenal.
US9829495B2 (en) 2015-08-13 2017-11-28 Corcept Therapeutics, Inc. Method for differentially diagnosing ACTH-dependent Cushing's syndrome
MX2018008849A (es) 2016-01-19 2019-01-31 Corcept Therapeutics Inc Diagnostico diferencial de sindrome de cushing ectopico.
WO2018236749A2 (en) 2017-06-20 2018-12-27 Corcept Therapeutics, Inc. METHODS OF TREATING NEURO-EPITHELIAL TUMORS USING GLUCOCORTICOID RECEPTOR SELECTIVE MODULATORS
WO2022130015A2 (en) 2020-12-18 2022-06-23 Instil Bio (Uk) Limited Processing of tumor infiltrating lymphocytes

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
US4780461A (en) * 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
DE3506785A1 (de) * 1985-02-22 1986-08-28 Schering AG, Berlin und Bergkamen, 1000 Berlin 11ss-n,n-dimethylaminophenyl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3625315A1 (de) * 1986-07-25 1988-01-28 Schering Ag 11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate
US5272140A (en) * 1987-01-23 1993-12-21 Akzo N.V. 11-aryl steroid derivatives
DE3723788A1 (de) * 1987-07-16 1989-01-26 Schering Ag 11(beta)-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate
BE1004905A4 (fr) * 1987-12-30 1993-02-23 Roussel Uclaf Nouveaux derives 17beta-oh 19-nor steroides substitues en 17alpha, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
US4954490A (en) * 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
DE3822770A1 (de) * 1988-07-01 1990-01-04 Schering Ag 13-alkyl-11ss-phenylgonane
DE3832303A1 (de) * 1988-09-20 1990-04-12 Schering Ag 11ss-phenyl-14ssh-steroide

Also Published As

Publication number Publication date
DE4042004A1 (de) 1992-06-25
HUT65320A (en) 1994-05-02
HU9301813D0 (en) 1993-09-28
ATE157372T1 (de) 1997-09-15
WO1992011278A1 (de) 1992-07-09
PT99910B (pt) 1999-06-30
FI932872A0 (fi) 1993-06-21
DE59108837D1 (de) 1997-10-02
EP0567469B1 (de) 1997-08-27
EP0567469A1 (de) 1993-11-03
CA2099016A1 (en) 1992-06-23
FI932872A (fi) 1993-06-21
JP3048636B2 (ja) 2000-06-05
US5426102A (en) 1995-06-20
IE914530A1 (en) 1993-06-30
PT99910A (pt) 1992-12-31
CN1066271A (zh) 1992-11-18
AU659118B2 (en) 1995-05-11
AU9111091A (en) 1992-07-22
JPH06505708A (ja) 1994-06-30

Similar Documents

Publication Publication Date Title
AU659118B2 (en) 14beta-H-, 14- and 15-EN-11beta -aryl-4-estrenes
IL105078A (en) Pharmaceutical compositions containing 17-(3-pyridyl)- substituted steroids and some new compounds of this type
KR950700318A (ko) 알칼리 금속 8,9-데하이드로에스트론 설페이트 에스테르(Alkali metal 8,9-dehydroestrone sulfate esters)
ES8305786A1 (es) "procedimiento de preparacion de nuevos derivados esteroides sustituidos en 11b".
ZA929859B (en) 19-nor steroids having a thiocarbon chain in position 11beta, their preparation process and the intermediates of this process, their use as medicaments and the pharmaceutical compositions containing them
PT79839B (en) Process for the preparation of 6,6-ethylene-15,16-methylene-3-oxi-17alpha-pregn-4-ene-21,17-carbolactones and pharmaceutical compositions therewith
AU664543B2 (en) D-homo-(16-EN)-11beta -aryl-4-estrenes, process for producing them and their use as medicaments
ZA9110144B (en) 6,7-modified 11beta-aryl-4-oestrenes
ES8702429A1 (es) Un procedimiento para la preparacion de derivados de d4-y-d5-androsteno nuevos
HUP0300887A2 (hu) Szteroid szerkezeteket tartalmazó gyógyszerkészítmények és alkalmazásuk
IL154828A0 (en) 17alpha FLUOROALKYL STEROIDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS
IL107232A0 (en) 19, 11-bridged 4-estrene derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
ES8305329A1 (es) Procedimiento para la preparacion de 4-(3-trifluormetilfenil)-1,2,3,6-tetrahidropiridinas.
NO932276L (no) D-homo-(16-en)-11beta-aryl-4-oestrener, fremgangsmaate for deres fremstilling, saa vel som deres anvendelse som legemiddel
MX9707610A (es) Derivados de fenoxietilamina que tienen una afinidad elevada hacia el receptor 5-ht1a, su procedimiento de preparacion, su aplicacion como medicamento y las composiciones farmaceuticas que los contienen.
GB928493A (en) Steroid compounds
RU95117929A (ru) Фармацевтическая композиция, ингибирующая костную резорбцию или промотирующая остеогенез
HUP0302020A2 (hu) 2-Szubsztituált pregna-1,3,5,(10)-trién- és kola-1,3,5(10)-trién-származékok, eljárás elżállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények